Low Molecular Weight Heparin Market Production, Share, Demand, Applications and Opportunities Market Research Report 2022
The Low Molecular Weight Heparin market analysis is provided for the Global Low Molecular Weight Heparin market including development trends, competitive landscape analysis, and key regions development status
(EMAILWIRE.COM, November 14, 2017 ) Market Overview:
"Low Molecular Weight Heparin (LMWHs) is derived from UFH (Unfractionated heparin) by such processes as chemical degradation, enzymatic depolymerisation and gamma-radiation cleavage.
Natural heparin consists of molecular chains of varying lengths, or molecular weights. Chains of varying molecular weights, from 5000 to over 40,000 Daltons, make up polydisperse pharmaceutical-grade heparin. LMWHs, in contrast, consist of only short chains of polysaccharide. LMWHs are defined as heparin salts having an average molecular weight of less than 8000 Da and for which at least 60% of all chains have a molecular weight less than 8000 Da."
Market Outlook
Low Molecular Weight Heparin is derived from an unfractionated heparin with an average molecular weight of less than 8,000 Da. Low molecular weight heparins are extracted by enzymatic or chemical depolymerization of unfractionated heparin. Low Molecular Weight Heparins have fewer side effects as compared to unfractionated heparins, which involve lesser risk of heparin-induced osteopenia and heparin-induced thrombocytopenia (HIT). Currently, Low Molecular Weight Heparin forms the standard of care drugs and is widely used for the treatment and prophylaxis of arterial and venous thrombosis. Dose consideration for low molecular weight heparin depends on a patients weight.
Get a Sample Copy of this Report @ https://www.precisemarketreports.com/report/sample/pmr-50185
Market Demand
Proven benefits of Low Molecular Weight Heparin over unfractionated heparin are driving the demand for low molecular weight heparin globally, which in turn is fuelling the growth of the market. The demand for low molecular weight heparin is expected to grow exponentially in the next few years due to increasing usage in surgeries and in the treatment of coagulation disorders. However, lack of its ability to reverse the effect of overdose resulting in the development of HIT and other bleeding disorders restrains the growth of the global low molecular weight heparin market.
Top Industries Players:
Aspen
Sanofi-aventis
Pfizer
Opocrin
CSBIO
Dongying Tiandong Pharmaceutical
Changzhou Qianhong Bio-pharma
Techdow
Yantai Dongcheng Pharmaceutical Group
Request Discount on this report @ https://www.precisemarketreports.com/report/discount/pmr-50185
Market Segmentation:
Market Segment by Type, covers
Enoxaparin
Dalteparin
Tinzaparin
Fraxiparine
Market Segment by Applications, can be divided into
Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter
Buy this report @ https://www.precisemarketreports.com/paypal/checkout/pmr-50185
About us:
Precise market reports, a one-stop research platform designed to help key decision makers and dynamic thought leaders across various industry verticals worldwide by making them aware of the past, current and future market scenario.
Tier 1's, SME's startups, top management consultants, have clearly visualized their environment using our analysis, thus enabling them to make critical business decisions and in devising a strategic plan.
Contact us:
Precise Market Reports
Office No. 48, Akshya Complex, Dhole Patil road,
Maharashtra, Pune 411001
India.
sales@precisemarketreports.com
+1 (323) 744 6588
https://www.precisemarketreports.com
"Low Molecular Weight Heparin (LMWHs) is derived from UFH (Unfractionated heparin) by such processes as chemical degradation, enzymatic depolymerisation and gamma-radiation cleavage.
Natural heparin consists of molecular chains of varying lengths, or molecular weights. Chains of varying molecular weights, from 5000 to over 40,000 Daltons, make up polydisperse pharmaceutical-grade heparin. LMWHs, in contrast, consist of only short chains of polysaccharide. LMWHs are defined as heparin salts having an average molecular weight of less than 8000 Da and for which at least 60% of all chains have a molecular weight less than 8000 Da."
Market Outlook
Low Molecular Weight Heparin is derived from an unfractionated heparin with an average molecular weight of less than 8,000 Da. Low molecular weight heparins are extracted by enzymatic or chemical depolymerization of unfractionated heparin. Low Molecular Weight Heparins have fewer side effects as compared to unfractionated heparins, which involve lesser risk of heparin-induced osteopenia and heparin-induced thrombocytopenia (HIT). Currently, Low Molecular Weight Heparin forms the standard of care drugs and is widely used for the treatment and prophylaxis of arterial and venous thrombosis. Dose consideration for low molecular weight heparin depends on a patients weight.
Get a Sample Copy of this Report @ https://www.precisemarketreports.com/report/sample/pmr-50185
Market Demand
Proven benefits of Low Molecular Weight Heparin over unfractionated heparin are driving the demand for low molecular weight heparin globally, which in turn is fuelling the growth of the market. The demand for low molecular weight heparin is expected to grow exponentially in the next few years due to increasing usage in surgeries and in the treatment of coagulation disorders. However, lack of its ability to reverse the effect of overdose resulting in the development of HIT and other bleeding disorders restrains the growth of the global low molecular weight heparin market.
Top Industries Players:
Aspen
Sanofi-aventis
Pfizer
Opocrin
CSBIO
Dongying Tiandong Pharmaceutical
Changzhou Qianhong Bio-pharma
Techdow
Yantai Dongcheng Pharmaceutical Group
Request Discount on this report @ https://www.precisemarketreports.com/report/discount/pmr-50185
Market Segmentation:
Market Segment by Type, covers
Enoxaparin
Dalteparin
Tinzaparin
Fraxiparine
Market Segment by Applications, can be divided into
Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter
Buy this report @ https://www.precisemarketreports.com/paypal/checkout/pmr-50185
About us:
Precise market reports, a one-stop research platform designed to help key decision makers and dynamic thought leaders across various industry verticals worldwide by making them aware of the past, current and future market scenario.
Tier 1's, SME's startups, top management consultants, have clearly visualized their environment using our analysis, thus enabling them to make critical business decisions and in devising a strategic plan.
Contact us:
Precise Market Reports
Office No. 48, Akshya Complex, Dhole Patil road,
Maharashtra, Pune 411001
India.
sales@precisemarketreports.com
+1 (323) 744 6588
https://www.precisemarketreports.com
Contact Information:
Precise Market Reports
Ashish M
Tel: +1 (323) 744 6588
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Precise Market Reports
Ashish M
Tel: +1 (323) 744 6588
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results